On April 1, 2021, a three-party project was initiated between the United States, the UK, and China that included the USDA, the U.S. National Poultry Research Center, the Southeast Poultry Research Laboratory (SEPRL) in Georgia, the Chinese Academy of Sciences (CAS), and the Roslin Institute in the UK.
The USDA is sponsoring a grant of $1 million for this project. The SEPRL and Roslin Institute provide expertise in avian immunology genomics and viral transcriptomics analysis.
The actual experiments are conducted in China’s CAS lab. There might be a specific reason for choosing this location.
The project, as we’ll explain later, is also a gain-of-function (GOF) study.
GOF studies on the bird flu virus have triggered broad criticism by the U.S. scientific community since 2011. Richard Ebright, a molecular biologist and laboratory director at the Waksman Institute of Microbiology, also told Science, “This work should never have been done.” From a biosafety perspective, scientists have expressed concern that a new virus generated through research could escape from the lab or that bioterrorists could leverage the published results into a bioweapon for malignant purposes.
In the United States, gain-of-function experiments involving influenza, Middle East respiratory syndrome coronavirus, and severe acute respiratory syndrome coronavirus were banned from October 2014 through December 2017. The moratorium was lifted by the National Institutes of Health (NIH) on Dec. 19, 2017.
Chinese labs often have sufficient technical capacity but face a major challenge due to relatively loose biosecurity regulations.
Former CDC director, Dr. Robert Redfield, recently stated, “Bird flu, I think, is going to be the cause of a great pandemic—where they are teaching these viruses how to be more infectious for humans.”
Hellbound and Down 